Screener
AdaptHealth AHCO Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by AdaptHealth in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: AdaptHealth’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030602
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash | $47,964 | $106,136 |
| Accounts receivable | 391,966 | 370,897 |
| Inventory | 159,269 | 151,247 |
| Prepaid and other current assets | 88,277 | 100,619 |
| Total current assets | 687,476 | 728,899 |
| Equipment and other fixed assets, net | 622,185 | 509,956 |
Item 1. Interim Consolidated Financial Statements (Unaudited)
FAQ
- What is AdaptHealth's cash & equivalents?
- AdaptHealth (AHCO) reported cash & equivalents of $47.96M in Q1 2026.
- How has AdaptHealth's cash & equivalents changed year-over-year?
- AdaptHealth's cash & equivalents decreased by 10.6% year-over-year, from $53.65M to $47.96M.
- What is the long-term trend for AdaptHealth's cash & equivalents?
- Over 5 years (2020 to 2025), AdaptHealth's cash & equivalents has grown at a 1.2% compound annual growth rate (CAGR), from $99.96M to $106.14M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about AdaptHealth's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude